Volume 16, Issue 1 (Spring 2024)                   2024, 16(1): 62-71 | Back to browse issues page

Ethics code: IR.SBMU.TEB.POLICE.REC.1402.003


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Jalili S, Panji M. Exploring the ceRNA Network in Multiple Sclerosis: Implications for B Cell Receptor Signaling Pathway and Therapeutic Targets. North Khorasan University of Medical Sciences 2024; 16 (1) :62-71
URL: http://journal.nkums.ac.ir/article-1-2926-en.html
1- Ph.D. in Biochemistry, Institute of Police Equipment and Technologies, Policing Sciences and Social Studies Research Institute, Tehran, Iran , jalili.shirin@yahoo.com
2- Ph.D. in Medical Biotechnology, Research Center for Life & Health Sciences & Biotechnology of the Police, Directorate of Health, Rescue & Treatment, Police Headquarter, Tehran, Iran
Abstract:   (771 Views)
Introduction: Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system and the second cause of disability in adults. The exact cause and pathogenic mechanisms behind this disease have not been yet understood. Besides T cells, B cells play a role in MS pathogenesis which has received less attention.
Method: In the current study, the expression of long non-coding RNAs and four genes of the B cell receptor signaling pathway (CR2, BLK, BLNK, and RASGRP3) were investigated in the GSE21942 microarray dataset. Then, miRNAs targeting these genes and lncRNAs were predicted using miRWalk and DIANA-LncBase databases. Finally, the ceRNA network was constructed using desired genes, lncRNAs, and predicted miRNAs.
Results: Seven differentially expressed lncRNAs were identified that all had high expression in MS patients compared with control subjects. Moreover, the expression levels of desired genes (CR2, BLK, BLNK, and RASGRP3) were upregulated in MS patients. Finally, the ceRNA network including one lncRNA (MALAT1), two predicted miRNAs (hsa-miR-92a-3p and hsa-miR-548a-3p), and three genes (CR2, RASGRP3, and BLK) was constructed. In this network, hsa-miR-92a-3p and hsa-miR-548a-3p target CR2, RASGRP3, and BLK genes, and MALAT1 constrains the effect of these miRNAs on desired genes through sponging them.
Conclusion: The constructed ceRNA network can be considered a novel mechanism of MS pathogenesis and may play a key role in MS development and progression by influencing the B cell receptor signaling pathway. Furthermore, each of the components of this network can be considered a potential therapeutic target.
Full-Text [PDF 1942 kb]   (205 Downloads)    
Type of Study: Orginal Research | Subject: Basic Sciences
Received: 2023/10/13 | Accepted: 2023/12/30 | Published: 2024/03/26

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of North Khorasan University of Medical Sciences

Designed & Developed by: Yektaweb